Abbvie invests in US expansion

Genmab to acquire Merus in USD8bn all-cash deal

ANGLE presents proof-of-concept data on circulating tumour cells in glioblastoma

Daiichi Sankyo and AstraZeneca's ENHERTU shows significant benefit over T-DM1 in phase 3 breast cancer trial

Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline

ME Therapeutics secures US patent for lead antibody and advances cancer programmes

OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University

Eli Lilly receives US FDA approval for Inluriyo

Biostar Pharma gains FDA orphan drug designation for Utidelone in pancreatic cancer

Hoth Therapeutics expands intellectual property portfolio for HT-001 in US

Lunit partners with CellCarta to expand access to digital pathology AI for clinical trials

Veracyte to present first prospective validation data for prostate cancer biomarker at ASTRO 2025

FDA grants priority review for Daiichi Sankyo and AstraZeneca's ENHERTU plus pertuzumab in first-line HER2 positive metastatic breast cancer

Eli Lilly plans new manufacturing facility in Houston, Texas

Mainz Biomed launches ColoAlert in Switzerland following regulatory approval and strategic partnership